Metabolic Effects of Buflomedil Hydrochloride

Balsano F Cordova C Musca A Violi F (1977a) Ruolo del metabolismo polmonare sulla emocoagulazione in fisiologia. in clinica ed in terapia. Clin. Ter. 80, 6, 513.

Balsano F Cordova C Musca A Perrone A Violi F Marigliano V (1977b) Insufficienza respiratoria cronica ed emocoagulazione: aspetti fisiopatologici e clinici. 78 Cngr. Soc. It. Med. Int. Firenze 19–22 Ottobre 1977.

Bignon J Aandreibongaran J Brouet G (1969) Etude autopsique angiographique des thromboembolies pulmonaires en réanimation respiratoire. Rev. Tuberc (Paris) 33, 597.

Braga P C Copponi V Cagnetta G (1980) The vasoactive effects of buflomedil on rabbit ears: in vivo macro and micro evidence. Clinical Trials Journal 17, (2), 64 and 17, (3), 130.

Branchereau A Fontaine G Devin R Codaccioni J L (1978) Etude d'un nouveau vaso-regulateur le chlorydrate de buflomedil. Tentative d'objectivation d'un éssai thérapeutique. Marseille Médical 166, 35.

Brecher G Bessis M (1972) Blood 40, 3.

Brenner D Birn M D Long M (1931) Sclerosis of the pulmonary artery with thrombosis. Lancet 1, 811.

Briguglio F Di Marco V Buta V Circosta C Ragusa S Briguglio E (1985) Su alcuni effetti metabolici del buflomedil cloridrato. (In corso di stampa).

Brooker G Thomas N J Appleman M M (1968) Biochemistry 7, 4177.

Brun J Ifayolle M Perrin Gardere J Pozzetto H Biot N Sab M (1973) Syndrome d'hypercoagulabilite sanguine et thromboses cardio-vasculaires au cours des insuffisances réspiratoire chronique. Rev. Prat. (Paris) 19, 219.

Brunetti P Puxeddu A Santeusanio F De Ciuceis P Siracusa A Arena D Migliorini E (1969) La anemia emolitica da difetto di piruvico-chinasi. Studio patogenetico. La Ricerca Clin. Lab. 9, 3.

Butcher T H , (1974) Biochem. Byophis. Acta (Amst.) 1, 292.

Chermet J (1976) Etude pharmacoclinique de l'activite, du LL 1656 par des artériographies périphériques. Médicine Praclicienne, 609, (1–2). January.

Cloarec M (1976) Traitment des troubles circulatoires périphériques. Etude clinique du LL 1656. La Vie Médicale 8, 427.

Cloarec M (1977) Traitment des troubles circulatoires provoqués par amantadine. La Medicine Praclicienne N. de Galaxie 3, 86.

Dacie J V Mollison P L Richardson N Selwin J G Saphiro L (1953) A typical congenital haemolytic anaemia. Q.I. Med. 85, 79.

Dern R J Brewer G I Wiorkowski J J (1967) Studies on the preservation of human blood. II The relationship of erythrocyte adenosine triphosphate levels and other in vitro measures to red cell storageability. J. Lab Clin. Med., 60, 968.

Di Marco V Buta V Circosta C Briguglio F (1985) Effetto del buflomedil cloridrato sul tenore di ATP eritrocitario in soggetti normali. (In corso di stampa).

Di Perri T (1981) Aspetti reologici della circolazione normale e patologica. Ati XI Sett. Ital. di Terapia. 12–16 Maggio 1981. Terme di Montecatini.

Puxeddu A Brunetti P Calabrese G Scionti L De Angelis M Pentiricci N Bolli G Ibenedetti M Massi (1979) Red cell 2,3 DPG levels in diabetic vasculopathy. Acta Diabet. Lat., 16, 311.

Le Devehat C Cirette B Lemoine A Ramet M (1980) Filtrabilitié sanguine et 2,3 DPG érythrocytayre chez le sujet diabètique. Angeiologe (Paris) 32, 317.

Pozza G Caradente O (1983) Alterazioni eritrocitarie nel diabete. La Ricerca Clin. Lab., 13, (Supp. 3), 159.

Dormandy J A (1983) L'influenza dell'emoreologia sulla pratica della medicina clinica. La Ricerca Clin. Lab., 13, (Supp. 3), 7.

Marcel G A George C Weil D Catry E Thaoichan M (1983) From Virchow to red cells. La Ricerca Clin. Lab., 13, (Supp. 3). 71.

Dormandy J A Ernst E (1981) Effect of buflomedil on erythrocyte deformability. Angiology 32, 714.

Ericson A De Verdier C H (1972) Scand. J. Clin. Lab. Inv., 29, 85.

Feo C I Leblond P F (1974) Blood 44, 639.

Gay G Vuillaume C (1977) Le buflomedil dans le traitement des artériopathies chroniques des membres inferieurs. Etude clinique et fonctionelle. Extrait des Ann. Med. de Nancy, 16, 1115.

Grellet J (1976) Mise in évidence par artériographie de l'action vaso-dilatatrice du LL 1656 injecté par voie veineuse. Médicine Interne 11, (10), 456.

Guerrini M Forconi S Di Perri T (1983) Terapie emoreologiche. Atti 5. Cong. Naz. Soc. Ital. di Pat. Vascol. Cagliari 8–11 Dic. 1983.

Hamberg M Svensson J Samuelsson B (1975) Thromboxanes a new group of biologically active compounds derived from prostaglandin endoperoxides. Proc. Nat. Acad. Sci., 72, 2994.

Kessler M Hoper J (1980) Decrease of O₂ uptake rate as induced by low PO₂ of the tissue. European Microcirculation Congress, Garmisch, Germany, September 13–20, Abstract 108.

Koerner K (1979) In vitro Untersuchungen von Vollblut und “buffycoat” freiem Erythrozytenkonsemengen und 0,4 mM Adenin. Blut 39, 285.

Landgraf H Lhrly A M Hildebrandt D (1980) Effect of buflomedil on muscle tissue PO₂ in patients with chronic occlusive arterial disease. XII World Congress of Angiology, Athens September, Abstract 516.

Leuenberger J Barras P Koerner K (1982) Rheological properties of erythrocytes stored as whole blood and as red blood cell concentrates: a comparative study. VASA, Band 11, Heft 1.

Mitchell R S Silvers G W Dart G A Petty T L Vincent T N Ryan S F Filley G F (1968) Clinical and morphological correlations in chronic airway obstruction. Am. Rev. Resp. Dis., 97, 54.

Muller R (1980) Concetti di emoreologia in farmacologia clinica. Therapiewoche 30, 2, 2440.

Serneri G G Neri (1983) Il ruolo delle piastrine e del sistema prosta-glandinico nell'ipertensione polmonare delle bronco-pneumopatie croniche ostruttive. Atti dei Seminari di Med. Interna 91–95. Punta Ala.

Nakao M Nakao T Yamazoe S (1969) Nature 187, 945.

Panuccio P (1980) L'ipertensione arteriosa polmonare. da Beretta Anguissola A.: Medicina Clinica Diagnostica e Terapia. Vol. VIII. C. G. E. Med. Scient. Torino, p 491.

Pariente R Cornu P Wanstok E Jeannin L Louet G (1972) Intéret du traitment anticoagulant au cours des poussées d'insuffisance respiratoire. Sem. Hop. Paris 48, (19), 1333.

Paunescu-Podeanu A Bratu C Tarachiu T Costocu M Brati V Bucur A (1973) Les thromboses pulmonaires qui compliquent l'insuffisance respiratoire et le coeur pulmonaire chronique. Med. It., 25, 137.

Perego M A (1981) Trattamento emoreologico nelle vasculopatie. Atti XI Sett. Ital di Terapie. 12–16 maggio 1981. Terme di Montecatini.

Reuse-Blom S (1979) Action of bufiomedil on normal and spasmed pial arterioles in the rabbit. Microvascular Research May 1979, 17, (3), part 2, Abstract 20.10.

Rogausch H (1978) Pflugers Arch., 373, 43.

Salomon Y (1979) Adenylate cyclase assay. In: Advances in cyclic nucleotide research. Vol. 10, p 35.

Schimid-Schonbein H (1980) Relazione al I International Congress on Microcirculation, Muenchen, Nov.

Schimid-Schonbein H (1981) Relazione al II International Congress on Microcirculation, Rio, Oct.

Steiner A L Kiplis D M Udiger R Parker C (1969) Proc. Nat. Acad. Sci. U.S., 64 367.

Shohet S B Ness P M (1977) Anemie emolitiche. Difetti delta membrana dei globuli rossi. La Clin. Med. del Nord Am., 9, 5, 975.

Valentine W C Tanaka K R Miwa S (1961) A specific erythrocyte glycolytic enzyme defect (pyruvate kinase) in three subjects with congenital non-spherocytic hemolytic anemia. Trans Assoc. Physicians, 74, 100.

Violi F (1982) Terapia antiaggregante piastrinica nel cuore polmonare cronico. Atti Simp. Satell. LXXXIII Cong. Soc. Ital. Med. Int., Roma 20 Ott. 1982, Masson Italia Editori.

Volger E Kerschbaum R Daum S (1982) Hemorrheological pulmonary hypertension. “Hypoxia”. Annual Meeting of European Society for Clinical Respiratory Physiology. Cefalú, 4–8 Oct. Abstract p 33.

Walcott G Burchell H B Brown A L jr (1970) Primary pulmonary hypertension. Am. J. Med., 49, 70.

Weed R J La Celle P L Merril E W (1969) Metabolic dependence of red cell deformability. J. Clin. Invest. 48, 795.

Weed R J Cahilly B (1973) In: Red cell shape, physiology, pathology ultrastructure. Edited by Bessis M Weed R J Leblond P F New York, Heidelberger, Berlin, Springer Verlag. p 55.

Zimmermann R E (1979) Biochemische Elementarvorgaenge del Haemostase. Med. Welt 16, 597.